Does your immune system learn like AI?
Could AI hold the key to answering questions that have stumped doctors and scientists for decades? A recent study at Cold Spring Harbor Laboratory (CSHL) borrows concepts from machine learning to address an age-old riddle of immunology.
In a groundbreaking study, researchers at Cold Spring Harbor Laboratory (CSHL) have discovered that the immune system learns to tolerate healthy tissue, much like artificial intelligence (AI) utilizes generalization techniques. By employing concepts from machine learning, scientists have found that the immune system's negative selection process plays a crucial role in avoiding attacks on healthy tissue.
During the thymus's training phase, T cells are tested against a fraction of the body's self-peptides to determine if they bind to them. T cells that bind to self-peptides are deleted, but the challenge lies in the fact that each T cell only encounters a small portion of the total self-peptides. This led scientists to wonder how the immune system learns to tolerate the rest.
By analyzing the process through the lens of machine learning, researchers found that two key conditions are necessary for generalization in the immune system. First, the abundance of self-peptides in the thymus closely resembles their abundance in other tissues, similar to how training data corresponds to test data in machine learning. Second, T-cell receptors are cross-reactive, meaning a single receptor can recognize multiple similar peptides, allowing T cells to learn about peptides they never directly encounter.
The study, published in Science Advances, demonstrates that 90% of self-reactive T cells can be correctly deleted in the thymus, even if each T cell only encounters 10% of the body's self-peptides. This suggests that the immune system achieves negative selection through a biological form of generalization.
Furthermore, the researchers explored whether failures in this generalization process could explain autoimmune diseases. To their surprise, their AI model accurately reproduced features of autoimmune polyendocrine syndrome type 1, a rare autoimmune disorder. By viewing the immune system as another form of AI, scientists may uncover new insights into human health and disease, marking the beginning of a new field called ImmunoAI.
Written by urgent.news from Medical Xpress's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
